Geneva, June 4 -- International Clinical Trials Registry received information related to the study (TCTR20250521002) titled 'Efficacy of a tooth foam and oral spray containing Cannabis sativa and Basella alba seed oil in reducing oral mucositis and xerostomia in patients receiving radiotherapy: An open-label randomized controlled trial' on May 21.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: Faculty of Dentistry, Chiangmai University

Condition: patients with head and neck cancer who are receiving radiotherapy, ASA class I or II oral mucositis, head and neck cancer, radiotherapy, radiation therapy, Cannabis saltiva, Basella alba,tooth foam oral mucositis, head and neck cancer, radiotherapy, radiation therapy,...